Amgen Tokenized Stock (Reality)
Amgen Inc. is a pioneering global biotechnology leader specializing in the discovery, development, and high-volume manufacturing of human genetics-based biologics. The company commands dominant therapeutic portfolios in bone health (Prolia), cardiovascular conditions (Repatha), and biosimilars. Backed by vast regulatory moats and steady cross-cycle pricing power, it functions as a highly defensive income-generating pharma asset.
Overview
Amgen Inc. is a pioneering global biotechnology leader specializing in the discovery, development, and high-volume manufacturing of human genetics-based biologics. The company commands dominant therapeutic portfolios in bone health (Prolia), cardiovascular conditions (Repatha), and biosimilars. Backed by vast regulatory moats and steady cross-cycle pricing power, it functions as a highly defensive income-generating pharma asset.
- Sector
- # RWA
Team
Team information has not been disclosed.
Funding history
0 disclosed roundsNo disclosed funding records.
Related news
Market updates
No related market updates.
People updates
No related people updates.